rosiglitazone has been researched along with ethidium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Choi, MJ; Chung, HK; Jo, YS; Jung, SB; Kim, HJ; Kim, KS; Kim, SJ; Kim, YK; Kweon, GR; Lee, CH; Lee, MH; Lee, SE; Ryu, MJ; Shong, M | 1 |
Elango, KP; Mahalakshmi, G; Ponkarpagam, S; Vennila, KN | 1 |
2 other study(ies) available for rosiglitazone and ethidium
Article | Year |
---|---|
Mitochondrial oxidative phosphorylation reserve is required for hormone- and PPARĪ³ agonist-induced adipogenesis.
Topics: 3T3-L1 Cells; Adipogenesis; Adiponectin; Animals; Cell Cycle Proteins; Cyclooxygenase 1; Ethidium; Fatty Acid Synthase, Type I; Gene Knockout Techniques; Membrane Proteins; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Phosphorylation; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2013 |
Multi-spectroscopic, voltammetric and molecular docking studies on binding of anti-diabetic drug rosigiltazone with DNA.
Topics: Binding, Competitive; Circular Dichroism; DNA; Electrochemical Techniques; Ethidium; Hypoglycemic Agents; Kinetics; Molecular Docking Simulation; Potassium Iodide; Proton Magnetic Resonance Spectroscopy; Rosiglitazone; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics; Viscosity | 2020 |